Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2805-2811
Published online before print May 23, 2005, doi: 10.1161/CIRCULATIONAHA.104.472886
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/21/2805    most recent
CIRCULATIONAHA.104.472886v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norata, G. D.
Right arrow Articles by Catapano, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norata, G. D.
Right arrow Articles by Catapano, A. L.
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Growth factors/cytokines
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2005;111:2805-2811.)
© 2005 American Heart Association, Inc.


Vascular Medicine

High-Density Lipoproteins Induce Transforming Growth Factor-ß2 Expression in Endothelial Cells

Giuseppe D. Norata, PhD; Elisa Callegari, BSc; Marta Marchesi, PhD; Giulia Chiesa, PhD; Per Eriksson, PhD; Alberico L. Catapano, PhD

From the Department of Pharmacological Sciences, University of Milan, Milan, Italy (G.D.N., E.C., M.M., G.C., A.L.C.); King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden (P.E.); and Centro per lo Studio, la Terapia e la Prevenzione delle Vasculopatie Periferiche, Ospedale Bassini, Cinisello Balsamo, Italy (A.L.C.).

Correspondence to Giuseppe Danilo Norata, PhD, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy. E-mail Danilo.Norata{at}unimi.it

Received May 5, 2004; revision received December 27, 2004; accepted January 11, 2005.

Background— HDL is endowed with cardiovascular protective activities. In addition to its role in reverse cholesterol transport, HDL influences different functions of endothelial cells. In the present study, we investigated in endothelial cells the genes involved in inflammation modulated by HDL.

Methods and Results— Through cDNA array analysis, transforming growth factor (TGF)-ß2 appeared to be a gene responsive to HDL treatment in endothelial cells. Quantitative real-time polymerase chain reaction confirmed that HDL subfraction 3 selectively induces TGF-ß2 mRNA expression and protein release, whereas TGF-ß1 and TGF-ß3 were not affected. This effect was mainly PI3K/Akt dependent. Lysosphingolipids present in HDL such as sphingosine 1 phosphate and sphingosylphosphorylcholine mimicked the effects of the whole HDL. These results were confirmed in vivo in transgenic mice overexpressing human apolipoprotein (apo) A-I. Compared with apoA-I–knockout mice, phospho-Akt, phospho-ERK1/2, and TGF-ß2 expression was increased in the aorta of transgenic mice overexpressing human apoA-I. In addition, the expression of phospho-Smad2/3, the transcription factor activated by TGF-ß, is increased in transgenic mice compared with knockout mice.

Conclusions— Because TGF-ß possesses antiinflammatory properties and stabilizes the plaque, the results of the present work suggest a novel target for the antiatherosclerotic effect of HDL.


Key Words: apolipoproteins • endothelium • lipoproteins • signal transduction




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. D. Norata, P. Marchesi, A. Pirillo, P. Uboldi, G. Chiesa, V. Maina, C. Garlanda, A. Mantovani, and A. L. Catapano
Long Pentraxin 3, a Key Component of Innate Immunity, Is Modulated by High-Density Lipoproteins in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. D. Norata, G. Tibolla, P. M. Seccomandi, A. Poletti, and A. L. Catapano
Dihydrotestosterone Decreases Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-Induced Inflammatory Response in Human Endothelial Cells
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 546 - 554.
[Abstract] [Full Text] [PDF]